PR Newswire: news distribution, targeting and monitoring
Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Market Videos
Currencies
International
Treasury & Bonds
Search InvestCenter
Recent Quotes
My Watchlist
Indicators
NEWLINK GENETICS (NQ: NLNK)
15.54 USD  -0.25 (-1.58%)
Official Closing Price  /  Updated: 4:00 PM EDT, May 22, 2013  /  Add to My Watchlist      
View: Quote News
All news about NEWLINK GENETICS
 
< Previous 1 2 3 Next >
NewLink Genetics to be Added to NASDAQ Biotechnology Index
May 16, 2013
category Other News , BIOTECHNOLOGY
from Latest eTeligis Press Releases with 'Plus' ranking
NewLink Genetics to Present Data on Cancer Immunotherapy Programs at the ASCO 2013 Annual Meeting
May 16, 2013
category Other News , BIOTECHNOLOGY
from Latest eTeligis Press Releases with 'Plus' ranking
NewLink Genetics to Be Added to NASDAQ Biotechnology Index
May 16, 2013
from Marketwired News Releases
NewLink Genetics to Present Data on Cancer Immunotherapy Programs at the ASCO 2013 Annual Meeting
May 16, 2013
Clinical Data Presented on Lead Drug Candidates From HyperAcute(TM) and IDO Pathway Platforms in Pancreatic Cancer, Non-Small Cell Lung Cancer and Other Metastatic Solid Tumors Read More
from Marketwired News Releases
Semi-Annual Changes to the NASDAQ Biotechnology Index
May 13, 2013
from GlobeNewswire News Releases
NewLink Genetics Corporation Reports First Quarter 2013 Financial Results
May 06, 2013
category Earnings Releases and Operating Results , BIOTECHNOLOGY
from Latest eTeligis Press Releases with 'Plus' ranking
Newlink Genetics (NLNK) Posts Q1 Loss of 33c/Share
May 06, 2013
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=8306284 for the full story. Read More
from StreetInsider.com News Articles
NewLink Genetics Corporation Reports First Quarter 2013 Financial Results
May 06, 2013
from Marketwired News Releases
NewLink Genetics to Present at the Needham and Company 12th Annual Healthcare Conference
April 25, 2013
category Other News , BIOTECHNOLOGY
from Latest eTeligis Press Releases with 'Plus' ranking
NewLink Genetics to Present at the Needham and Company 12th Annual Healthcare Conference
April 25, 2013
from PR Newswire
NewLink Genetics Presents Preclinical Data on New IDO Pathway Inhibitor, NLG919, at AACR 2013 Annual Meeting
April 08, 2013
category Other News , BIOTECHNOLOGY
from Latest eTeligis Press Releases with 'Plus' ranking
NewLink (NLNK) to Present Favorable Data from Preclinical NLG919 Trial
April 08, 2013
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=8237535 for the full story. Read More
from StreetInsider.com News Articles
NewLink Genetics Presents Preclinical Data on New IDO Pathway Inhibitor, NLG919, at AACR 2013 Annual Meeting
April 08, 2013
Results Support Further Evaluation of NLG919 for the treatment of Immunosupression Associated with Cancers Read More
from PR Newswire
NewLink Genetics Presents Preclinical Data on NLG919, a New Drug Candidate from a Novel Class of IDO Pathway Inhibitors for the Treatment of Cancer
April 04, 2013
category Other News , BIOTECHNOLOGY
from Latest eTeligis Press Releases with 'Plus' ranking
NewLink Genetics Presents Preclinical Data on NLG919, a New Drug Candidate from a Novel Class of IDO Pathway Inhibitors for the Treatment of Cancer
April 04, 2013
from PR Newswire
NewLink Genetics Initiates Phase 2 Trial of IDO Pathway Inhibitor, Indoximod, for the Treatment of Metastatic Breast Cancer
April 02, 2013
category Other News , BIOTECHNOLOGY
from Latest eTeligis Press Releases with 'Plus' ranking
NewLink Genetics (NLNK) Commences Indoximod Phase 2 in Metastatic Breast Cancer
April 02, 2013
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=8223752 for the full story. Read More
from StreetInsider.com News Articles
NewLink Genetics Initiates Phase 2 Trial of IDO Pathway Inhibitor, Indoximod, for the Treatment of Metastatic Breast Cancer
April 02, 2013
Clinical Trial Designed to Evaluate Novel IDO Pathway Inhibitor in Combination with Docetaxel Read More
from PR Newswire
Mentor Capital Cancer Immunotherapy Index Gains 32% YTD and Adds Second Generation Firms for 2013
March 15, 2013
from Business Wire News Releases
Biotech. Stocks Recap: Cleveland BioLabs, Progenics Pharmaceuticals, NewLink Genetics Corp, StemCells
March 01, 2013
Lakeway, TX -- (SBWIRE) -- 03/01/2013 -- vbtrendreport.com, an investment community with a special focus on updating investors with recent news on the U.S. stock market, issues news alert on the... Read More
from SBWire - Latest Press Releases
NewLink Genetics Reports Fourth Quarter and Full-Year 2012 Financial Results
February 28, 2013
category Company Announcement , ADVISORY
from Latest eTeligis Press Releases with 'Plus' ranking
Newlink Genetics (NLNK) Tops Q4 Loss Views by 2c/Share
February 28, 2013
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=8142038 for the full story. Read More
from StreetInsider.com News Articles
NewLink Genetics Reports Fourth Quarter and Full-Year 2012 Financial Results
February 28, 2013
Conference Call Scheduled for February 28, 2013 Read More
from Marketwired News Releases
NewLink Genetics Announces Timing of Fourth Quarter and Year-End 2012 Financial Results Conference Call
February 25, 2013
category Earnings Releases and Operating Results , BIOTECHNOLOGY
from Latest eTeligis Press Releases with 'Plus' ranking
NewLink Genetics Announces Timing of Fourth Quarter and Year-End 2012 Financial Results Conference Call
February 25, 2013
from PR Newswire
[(NLNK)] NEWLINK GENETICS CORP ($10,032,000 traded)
February 05, 2013
[(NLNK)] has 1 insider trade(s) from 2013-01-29 to 2013-02-05, the net trade amount is $10,032,000 USD. Read More
from Top 10 Companies Net Insider BUY (By $ Amount in USD)
NewLink Genetics Corporation Announces Exercise of Underwriters' Option and Closing of Public Offering of Common Stock
February 04, 2013
from PR Newswire
Micro Cap Stocks Alert (BIOC, GEVO, PVA, NLNK, XOMA)
January 30, 2013
Houston, TX -- (SBWIRE) -- 01/30/2013 -- AnotherWinningTrade.com offers its daily alerts and market content newsletter to investors looking for the best information available! AnotherWinningTrade.com... Read More
from SBWire - Latest Press Releases
NewLink (NLNK) Prices 4M Offering at $11.40/Share
January 30, 2013
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=8042414 for the full story. Read More
from StreetInsider.com News Articles
NewLink Genetics Corporation Announces Pricing of Public Offering of Common Stock
January 30, 2013
from PR Newswire
< Previous 1 2 3 Next >
Stock Market XML and JSON Data API provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Press Release Service provided by PRConnect.
Stock quotes supplied by Telekurs USA
Postage Rates Bots go here
Advanced Search
Search
  
  1. Products & Services
  2. Knowledge Center
  3. Browse News Releases
  4. Contact PR Newswire